Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus 1% ophthalmic drops versus dexamethasone 1% ophthalmic drops for shield ulcer
IRCT2016110630746N1Phase 2Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tacrolimus and dexamethasone in Shield ulcer (2 arms), sponsored by Zahedan University of Medical Sciences. Started Jul 2015; status: completed.
02
Drugs
tacrolimusdexamethasone
03
Conditions
Shield ulcer
Beyond the preview
Go deeper on IRCT2016110630746N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016110630746N1.